Cargando…

Withdrawal Notice

Withdrawal Notice: Zhu, Y, Pu, Q, Zhang, Q, et al. Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small‐cell lung cancer. Cancer Med. 2022; 00: 1‐22. doi: 10.1002/cam4.5306. The above article, published online on 13th November 2022 in W...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557851/
https://www.ncbi.nlm.nih.gov/pubmed/36372952
http://dx.doi.org/10.1002/cam4.5306
_version_ 1785117160954134528
collection PubMed
description Withdrawal Notice: Zhu, Y, Pu, Q, Zhang, Q, et al. Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small‐cell lung cancer. Cancer Med. 2022; 00: 1‐22. doi: 10.1002/cam4.5306. The above article, published online on 13th November 2022 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/10.1002/cam4.5306), has been withdrawn by agreement between the journal Editor in Chief, Dr Stephen Tait, the Authors, and John Wiley & Sons, Ltd. The withdrawal has been agreed due to an editorial office error that led to the publication of the article without peer review. The revised article, which has undergone peer review may be read here: https://onlinelibrary.wiley.com/doi/10.1002/cam4.6309.
format Online
Article
Text
id pubmed-10557851
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105578512023-10-07 Withdrawal Notice Cancer Med Withdrawal Notice Withdrawal Notice: Zhu, Y, Pu, Q, Zhang, Q, et al. Selenium‐binding protein 1 inhibits malignant progression and induces apoptosis via distinct mechanisms in non‐small‐cell lung cancer. Cancer Med. 2022; 00: 1‐22. doi: 10.1002/cam4.5306. The above article, published online on 13th November 2022 in Wiley Online Library (https://onlinelibrary.wiley.com/doi/10.1002/cam4.5306), has been withdrawn by agreement between the journal Editor in Chief, Dr Stephen Tait, the Authors, and John Wiley & Sons, Ltd. The withdrawal has been agreed due to an editorial office error that led to the publication of the article without peer review. The revised article, which has undergone peer review may be read here: https://onlinelibrary.wiley.com/doi/10.1002/cam4.6309. John Wiley and Sons Inc. 2022-11-13 /pmc/articles/PMC10557851/ /pubmed/36372952 http://dx.doi.org/10.1002/cam4.5306 Text en © 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Withdrawal Notice
Withdrawal Notice
title Withdrawal Notice
title_full Withdrawal Notice
title_fullStr Withdrawal Notice
title_full_unstemmed Withdrawal Notice
title_short Withdrawal Notice
title_sort withdrawal notice
topic Withdrawal Notice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557851/
https://www.ncbi.nlm.nih.gov/pubmed/36372952
http://dx.doi.org/10.1002/cam4.5306